---
title: Characterization of Vascular Niche in Systemic Sclerosis by Spatial Proteomics
date: '2024-03-05'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38440901/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240305170555&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: Using spatial proteomics, we unraveled the heterogeneity
  of vascular cells in control individuals and patients with SSc. We identified CD34^(+);αSMA^(+);CD31^(+)
  VECs as a novel endothelial cell population that is increased in patients with SSc,
  expresses markers for endothelial-to-mesenchymal transition, and is located in close
  proximity to immune cells and myofibroblasts. CD34^(+);αSMA^(+);CD31^(+) VEC counts
  were associated with clinical outcomes of progressive ...'
disable_comments: true
---
CONCLUSIONS: Using spatial proteomics, we unraveled the heterogeneity of vascular cells in control individuals and patients with SSc. We identified CD34^(+);αSMA^(+);CD31^(+) VECs as a novel endothelial cell population that is increased in patients with SSc, expresses markers for endothelial-to-mesenchymal transition, and is located in close proximity to immune cells and myofibroblasts. CD34^(+);αSMA^(+);CD31^(+) VEC counts were associated with clinical outcomes of progressive ...